English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/216748
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Targeted resequencing reveals rare variants enrichment in multiple sclerosis susceptibility genes

AuthorsGil-Varea, E.; Spataro, N.; Villar, L.M.; Tejeda-Velarde, A.; Midaglia, L.; Matesanz, F.; Malhotra, S.; Eixarch, H.; Patsopoulos, N.; Fernández, Ó.; Oliver-Martos, B.; Saiz, A.; Llufriu, S.; Ramió-Torrentà, L.; Quintana, E.; Izquierdo, G.; Alcina, Antonio; Bosch, E.; Navarro, A.; Montalban, X.; Comabella, M.
KeywordsRGS1
interferon-β
multiple sclerosis
rare variants
single nucleotide polymorphisms
targeted DNA sequencing
Issue Date2020
PublisherJohn Wiley & Sons
CitationHuman Mutation (2020)
AbstractAlthough genome-wide association studies have identified a number of common variants associated with multiple sclerosis (MS) susceptibility, little is known about the relevance of rare variants. Here, we aimed to explore the role of rare variants in 14 MS risk genes (FCRL1, RGS1, TIMMDC1, HHEX, CXCR5, LTBR, TSFM, GALC, TRAF3, STAT3, TNFSF14, IFI30, CD40, and CYP24A1) by targeted resequencing in an Iberian population of 524 MS cases and 546 healthy controls. Four rare variants-enriched regions within CYP24A1, FCRL1, RGS1, and TRAF3 were identified as significantly associated with MS. Functional studies revealed significantly decreased regulator of G protein signaling 1 (RGS1) gene expression levels in peripheral blood mononuclear cells from MS patients with RGS1 rare variants compared to noncarriers, whereas no significant differences in gene expression were observed for CYP24A1, FCRL1, and TRAF3 between rare variants carriers and noncarriers. Immunophenotyping showed significant decrease in RGS1 expression in peripheral blood B lymphocytes from MS patients with RGS1 rare variants relative to noncarriers. Lastly, peripheral blood mononuclear cell from MS patients carrying RGS1 rare variants showed significantly lower induction of RGS1 gene expression by interferon-β compared to MS patients lacking RGS1 variants. The presence of rare variants in RGS1 reinforce the ideas of high genetic heterogeneity and a role of rare variants in MS pathogenesis.
Publisher version (URL)http://dx.doi.org/10.1002/humu.24016
URIhttp://hdl.handle.net/10261/216748
Identifiersdoi: 10.1002/humu.24016
issn: 1059-7794
e-issn: 1098-1004
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.